Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kaye

Showing results (411-420 of 418) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 418 results.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.
Nature Methods|October 25, 2011
NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytesDavid A Elliott, Stefan R Braam, Katerina Koutsis, et al.
JACC. Heart Failure|June 10, 2026
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF IIShunichi Doi, Sho Kazui, Naoyuki Akashi, et al.
European Heart Journal|August 29, 2025
Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trialLouise Segan, Peter M Kistler, Shane Nanayakkara, et al.
JACC. Basic to Translational Science|October 24, 2025
CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial InfarctionAascha A D'Elia Nee Brown, Helen Kiriazis, Jason Bloom, et al.
JACC. Heart Failure|March 20, 2023
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection FractionSheldon E Litwin, Jan Komtebedde, Mo Hu, et al.
Circulation|March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureBarry A Borlaug, John Blair, Martin W Bergmann, et al.
Pageof 42

Showing results (411-420 of 418) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 418 results.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.
Nature Methods|October 25, 2011
NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytesDavid A Elliott, Stefan R Braam, Katerina Koutsis, et al.
JACC. Heart Failure|June 10, 2026
Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF IIShunichi Doi, Sho Kazui, Naoyuki Akashi, et al.
European Heart Journal|August 29, 2025
Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trialLouise Segan, Peter M Kistler, Shane Nanayakkara, et al.
JACC. Basic to Translational Science|October 24, 2025
CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial InfarctionAascha A D'Elia Nee Brown, Helen Kiriazis, Jason Bloom, et al.
JACC. Heart Failure|March 20, 2023
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection FractionSheldon E Litwin, Jan Komtebedde, Mo Hu, et al.
Circulation|March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureBarry A Borlaug, John Blair, Martin W Bergmann, et al.
Pageof 42